Follow
James Johnston
James Johnston
Clinical Professor, BCCDC and UBC Respiratory Medicine
Verified email at bccdc.ca - Homepage
Title
Cited by
Cited by
Year
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
ML Bastos, G Tavaziva, SK Abidi, JR Campbell, LP Haraoui, JC Johnston, ...
bmj 370, 2020
9422020
Whole-genome sequencing and social-network analysis of a tuberculosis outbreak
JL Gardy, JC Johnston, SJH Sui, VJ Cook, L Shah, E Brodkin, S Rempel, ...
New England Journal of Medicine 364 (8), 730-739, 2011
8872011
Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis
JC Johnston, NC Shahidi, M Sadatsafavi, JM Fitzgerald
PloS one 4 (9), e6914, 2009
5922009
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
5112013
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis
MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ...
Nature genetics 45 (10), 1183-1189, 2013
4992013
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
3082018
A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations
AS Shah, AW Wong, CJ Hague, DT Murphy, JC Johnston, CJ Ryerson, ...
Thorax 76 (4), 402-404, 2021
2102021
Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis
K Romanowski, B Baumann, CA Basham, FA Khan, GJ Fox, JC Johnston
The Lancet Infectious Diseases 19 (10), 1129-1137, 2019
1942019
Patient-reported outcome measures after COVID-19: a prospective cohort study
AW Wong, AS Shah, JC Johnston, C Carlsten, CJ Ryerson
European Respiratory Journal 56 (5), 2020
1932020
Tuberculosis and chronic kidney disease: an emerging global syndemic
K Romanowski, EG Clark, A Levin, VJ Cook, JC Johnston
Kidney international 90 (1), 34-40, 2016
1352016
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ...
The Lancet Microbe 3 (4), e265-e273, 2022
1192022
Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis
P Weiss, W Chen, VJ Cook, JC Johnston
BMC infectious diseases 14 (1), 1-9, 2014
1012014
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
F Fregonese, SD Ahuja, OW Akkerman, D Arakaki-Sanchez, I Ayakaka, ...
The Lancet Respiratory Medicine 6 (4), 265-275, 2018
1002018
Diagnostic accuracy of stool Xpert MTB/RIF for detection of pulmonary tuberculosis in children: a systematic review and meta-analysis
E MacLean, G Sulis, CM Denkinger, JC Johnston, M Pai, F Ahmad Khan
Journal of clinical microbiology 57 (6), 10.1128/jcm. 02057-18, 2019
892019
Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis
JP Samuels, A Sood, JR Campbell, FA Khan, JC Johnston
Nature Scientific reports 8 (1), 4980, 2018
862018
Chest x-ray analysis with deep learning-based software as a triage test for pulmonary tuberculosis: a prospective study of diagnostic accuracy for culture-confirmed disease
FA Khan, A Majidulla, G Tavaziva, A Nazish, SK Abidi, A Benedetti, ...
The Lancet Digital Health 2 (11), e573-e581, 2020
832020
Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis
K Al-Efraij, L Mota, C Lunny, M Schachter, V Cook, J Johnston
The International journal of tuberculosis and lung disease 19 (12), 1493-1499, 2015
812015
Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery
Journal of British Surgery 107 (2), e161-e169, 2020
562020
Mycobacterium kasasii
EK Johnston JC, Chiang L
Microbiology Spectrum 5 (1), 2017
56*2017
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
JR Campbell, A Trajman, VJ Cook, JC Johnston, M Adjobimey, R Ruslami, ...
The Lancet Infectious Diseases 20 (3), 318-329, 2020
552020
The system can't perform the operation now. Try again later.
Articles 1–20